The influence of CCPA and RF on the five-year outcomes in patients with early rheumatoid arthritisиве by Ermakova Yu.A., Karateev D.E., Luchikhina E.L., Demidova N.V.

Get full text

Disparities in rheumatoid arthritis disease activity according to gross domestic product in 25 countries in the QUEST-RA database. by Sokka, T, Kautiainen, H, Pincus, T, Toloza, S, da Rocha Castelar Pinheiro, G, Lazovskis, J, Hetland, M, Peets, T, Immonen, K, Maillefert, J, Drosos, A, Alten, R, Pohl, C, Rojkovich, B, Bresnihan, B, Minnock, P, Cazzato, M, Bombardieri, S, Rexhepi, S, Rexhepi, M, Andersone, D, Stropuviene, S, Huisman, M, Sierakowski, S, Karateev, D

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update by Smolen, J, Landewé, R, Bijlsma, J, Burmester, G, Chatzidionysiou, K, Dougados, M, Nam, J, Ramiro, S, Voshaar, M, van Vollenhoven, R, Aletaha, D, Aringer, M, Boers, M, Buckley, C, Buttgereit, F, Bykerk, V, Cardiel, M, Combe, B, Cutolo, M, van Eijk-Hustings, Y, Emery, P, Finckh, A, Gabay, C, Gomez-Reino, J, Gossec, L, Gottenberg, J, Hazes, J, Huizinga, T, Jani, M, Karateev, D, Kouloumas, M, Kvien, T, Li, Z, Mariette, X, McInnes, I, Mysler, E, Nash, P, Pavelka, K, Poór, G, Richez, C, van Riel, P, Rubbert-Roth, A, Saag, K, da Silva, J, Stamm, T, Takeuchi, T, Westhovens, R, de Wit, M, van der Heijde, D